The abstract is read at the publisher; the summary is JClub's.
Rare monoallelic protein-altering ZNF536 variants are linked to a neurodevelopmental disorder in 21 affected individuals, with 15/18 predicted loss-of-function alleles and prominent behavioral features.
- Why it matters: The study addresses whether rare, protein-altering ZNF536 variants contribute to human disease beyond prior GWAS signals for schizophrenia at the locus.
- What they did: An international cohort assembled 21 affected people with 18 unique rare heterozygous ZNF536 variants, and functional effects were tested using a Zfp536 p.Gln169Ter knock-in mouse model.
- The result: In mice, heterozygous mutants survived but showed autism-like behaviors, increased anxiety, and impaired recognition memory, alongside reduced cortical size, thickness, and deep-layer neuronal density.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.